Phillip Securities Palantir · PLTR

Phillip Securities Downgrades Palantir to Neutral, $215 Price Target

October 12, 2026 Analyst: Alif Fahmi 1 min read Reproduced verbatim
Rating
Hold
from Buy
Target
$215
Unchanged
Upside
+3%
PLTR at $209 today
Phillip Securities and Palantir logos

What the analyst said

Phillip Securities analyst Alif Fahmi downgraded Palantir (NASDAQ: PLTR) from Buy to Neutral with a price target of $215.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

PLTR trades at $209. The 17 analysts who set a target in the last 3 months range from $90 to $265, with a median of $230. This $215 target is 7% below the median.

12-month window: day 0 of 365, closes on October 12, 2027.

Track record

This callOpen: a 12-month target, scored on October 12, 2027, a year after the note.

Firm track recordToo early to score Phillip Securities: price targets are 12-month calls and fewer than 3 of its targets are a year old. 1 of its 6 open targets have already been reached. How we score

Phillip Securities on Palantir

Phillip Securities price targets on Palantir

2 calls from August 11, 2026 to October 12, 2026. The target stayed at $215. The rating moved from Buy to Hold.

Phillip Securities targetPLTR share price
  1. October 12, 2026 This noteDowngraded to Hold, kept the $215 targetHold$215
  2. August 11, 2026Earliest call shownBuy$215
Share

Other analysts on Palantir

BairdBuy Raised price target +25%, kept rating · Oct 12 $250from $200 BarclaysBuy Initiated coverage · Oct 8 $265 Goldman SachsBuy Upgraded · Oct 8 $230 Yorkville IvesBuy Initiated coverage · Oct 7 $250 StoneXHold Kept rating · Sep 30
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.